Hormone replacement therapy is associated with reduced hepatocellular carcinoma risk and improved survival in postmenopausal women with hepatitis B: A nationwide long-term population-based cohort study

Postmenopausal women with hepatitis B virus (HBV) infection are more likely to have accelerated liver fibrosis, eventually advancing to liver cirrhosis or hepatocellular carcinoma (HCC). The association between sex hormones and HBV-related HCC risk is unclear. We investigated whether hormone replace...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chun-Hsiang, Lin, Ruey-Chang, Hsu, Hua-Yin, Tseng, Yuan-Tsung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302748/
https://www.ncbi.nlm.nih.gov/pubmed/35862398
http://dx.doi.org/10.1371/journal.pone.0271790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302748/
https://www.ncbi.nlm.nih.gov/pubmed/35862398
http://dx.doi.org/10.1371/journal.pone.0271790

Ejemplares similares